BIOMAT Database Logo BIOMAT Database Logo

[Neonatal screening for congenital hypothyroidism and phenylketonuria]. 1994

A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Unidad de Genética de la Nutrición, Universidad Nacional Autónoma de México.

A newborn screening program for congenital hypothyroidism (CH) and phenylketonuria (PKU) was conducted in 140 163 infants from the Federal District and the states of Mexico and Tlaxcala. These children were born mainly in hospitals for the non-insured population, although some were social security beneficiaries. Their filter-paper blood TSH and phenylalanine concentrations were determined 48 hours after birth. The frequency of CH was 1:1 797, with a 95 per cent confidence interval of 1:1 470 to 1:2 315, and was quite similar in the different types of hospitals. Only two PKU cases were found, for a frequency of 1:70 082, with a 95 per cent confidence interval of 0 to 1:4 762. This work demonstrates the feasibility of newborn screening programs in Mexico, identifies the problems to be solved in order to achieve a wide coverage and establishes the high frequency of CH in the Mexican population.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D003409 Congenital Hypothyroidism A condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA. Cretinism,Myxedema, Congenital,Endemic Cretinism,Fetal Iodine Deficiency Disorder,Cretinism, Endemic,Hypothyroidism, Congenital
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Neonatal screening for congenital hypothyroidism and phenylketonuria in China.
May 2009, World journal of pediatrics : WJP,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
November 2005, Journal of paediatrics and child health,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Audit of neonatal screening programme for phenylketonuria and congenital hypothyroidism.
November 1997, Archives of disease in childhood. Fetal and neonatal edition,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
[Neonatal screening for phenylketonuria and hypothyroidism].
October 2000, La Revue du praticien,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Neonatal screening of phenylketonuria and congenital hypothyroidism in China.
January 1999, The Southeast Asian journal of tropical medicine and public health,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
[A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
May 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Phenylketonuria and neonatal hypothyroidism in Spain. Priority of screening for neonatal hypothyroidism.
May 1980, European journal of pediatrics,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
[National screening for phenylketonuria, congenital hypothyroidism and congenital adrenal hyperplasia].
March 1992, Acta medica portuguesa,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
[Neonatal screening for congenital hypothyroidism].
January 1997, Acta medica Austriaca,
A Velázquez, and A Loera-Luna, and B E Aguirre, and S Gamboa, and H Vargas, and C Robles
Neonatal screening for congenital hypothyroidism.
November 1980, Pediatric clinics of North America,
Copied contents to your clipboard!